METASTATIC RENAL CELL CARCINOMA
Clinical trials for METASTATIC RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney removal debate: landmark trial tests surgery plus drug vs. drug alone
Disease control CompletedThis study looked at 452 people with advanced kidney cancer that had spread. It compared the standard approach of surgically removing the kidney (nephrectomy) followed by the drug sunitinib, versus taking sunitinib alone without surgery. The main goal was to see which group lived…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 03:16 UTC
-
New drug duo shows promise for tough-to-treat kidney cancer
Disease control CompletedThis study tested a combination of two immunotherapy drugs (nivolumab and ipilimumab) against standard treatments for people with a rare and advanced form of kidney cancer called non-clear cell renal cell carcinoma. The main goal was to see if the drug combination helped patients…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Real-World data reveals effectiveness of immunotherapy combos for advanced kidney cancer
Knowledge-focused CompletedThis study looked at medical records from 494 adults with advanced kidney cancer to see how well first-line immunotherapy combinations work and what happens when patients switch to other treatments. Researchers tracked how long patients stayed on treatment, their response to ther…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 17, 2026 03:12 UTC